AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 53 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,162,829 | -2.3% | 928,253 | -0.2% | 0.67% | +11.2% |
| Q2 2023 | $2,214,338 | +2.3% | 930,394 | -20.9% | 0.60% | -6.8% |
| Q1 2023 | $2,164,116 | -3.2% | 1,176,150 | 0.0% | 0.65% | +3.2% |
| Q4 2022 | $2,234,685 | +110.4% | 1,176,150 | +137.1% | 0.63% | +119.9% |
| Q3 2022 | $1,062,000 | -24.4% | 496,150 | 0.0% | 0.29% | -25.3% |
| Q2 2022 | $1,404,000 | -32.1% | 496,150 | 0.0% | 0.38% | -28.9% |
| Q1 2022 | $2,069,000 | +100.9% | 496,150 | +672.4% | 0.54% | +81.5% |
| Q2 2020 | $1,030,000 | -21.8% | 64,235 | -70.8% | 0.30% | -46.0% |
| Q1 2020 | $1,317,000 | -0.2% | 219,800 | +119.8% | 0.55% | +21.4% |
| Q4 2019 | $1,320,000 | +6.3% | 100,000 | 0.0% | 0.45% | -3.0% |
| Q3 2019 | $1,242,000 | -22.9% | 100,000 | 0.0% | 0.47% | -22.8% |
| Q2 2019 | $1,610,000 | – | 100,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |